Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Asia-wide, Multicenter Open-label, Phase II Non-randomised Study Involving Children With Down Syndrome Under 21 Year-old With Newly Diagnosed, Treatment naïve Acute Lymphoblastic Leukemia

NCT03286634 is registered in ClinicalTrials.gov with National Hospital Organization Nagoya Medical Center as lead sponsor.

NCT NCT03286634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03286634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Asia-wide, Multicenter Open-label, Phase II Non-randomised Study Involving Children With Down Syndrome Under 21 Year-old With Newly Diagnosed, Treatment naïve Acute Lymphoblastic Leukemia
Lead sponsor
National Hospital Organization Nagoya Medical Center
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 18, 2017
Completion date
March 31, 2033
Enrollment
60 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, childhood cancer, down syndrome